Animal models for investigating the causes and mechanisms of mammalian germ cell aneuploidy

Source Book of Models for Biomedical Research

Volumn , Issue , 2008, Pages 527-537

  Mailhes, John B ^a   Handel, Mary Ann ^b  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

Aneuploidy; Animal models; Female germ cells; Male germ cells; Molecular mechanisms

Indexed keywords

EID: 84866408938     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-285-4_54     Document Type: Chapter

References (168)

1. Hassold T, Hunt PA. To err (meiotically) is human: The genesis of human aneuploidy. Nat Rev Genet 2001;2:280-291.
2. Ford JH. Nondisjunction. In: Burgio GR, Fraccaro M, Tiepolo L, Wolf U, Eds. Trisomy 21. Berlin: Springer-Verlag,1981:103-143.
3. Hansmann I. Factors and mechanisms involved in nondisjunction and X-chromosome loss. In: Sandberg AA, Ed. Cytogenetics of the Mammalian X Chromosome, Part A: Progress and Topics in Cytogenetics, Vol. 3A. New York: Alan R. Liss, 1983:131-170.
4. Bond DJ, Chandley AC. Aneuploidy. Oxford Monographs on Medical Genetics, No. 11. Oxford, UK: Oxford University Press, 1983.
5. Hook EB. The impact of aneuploidy upon public health: Mortality and morbidity associated with human chromosome abnormalities. In: Dellarco VL, Voytek PE, Hollaender A, Eds. Aneuploidy: Etiology and Mechanisms. New York: Plenum Press, 1985:7-33.
6. Hecht F, Hecht BK. Aneuploidy in humans: Dimensions, demography, and dangers of abnormal numbers of chromosomes. In: Vig BK, Sandberg AA, Eds. Aneuploidy, Part A: Incidence and Etiology. New York: Alan R. Liss, 1987:9-49.
7. Hook EB. Maternal age, paternal age, and human chromosome abnormality: Nature, magnitude, etiology, and mechanisms of effects. In: Dellarco VL, Voytek PE, Hollaender A, Eds. Aneuploidy: Etiology and Mechanisms. New York: Plenum Press, 1985: 117-132.
8. Chandley AC. Aneuploidy: An overview. In: Vig BK, Sandberg AA, Eds. Aneuploidy: Part A: Incidence and Etiology. New York: Alan R. Liss, 1987:1-8.
9. Lamson SH, Hook EB. A simple function for maternal age-specifi c rates of Down syndrome in the 20-to-48 year age range and its biological implications. Am J Hum Genet 1980;32:743-753.
10. Hassold T, Chiu D, Yamane JA. Parental origin of autosomal trisomies. Ann Hum Genet 1984;48:129-144.
11. Hassold TJ. The origin of aneuploidy in humans. In: Dellarco VL, Voytek PE, Hollaender A, Eds. Aneuploidy: Etiology and Mechanisms. New York: Plenum Press, 1985:103-115.
12. Nicolaidis P, Petersen MB. Origin and mechanisms of nondisjunction in human autosomal trisomies. Hum Reprod 1998;13: 313-319.
13. Henderson SA, Edwards RG. Chiasma frequency and maternal age in mammals. Nature 1968;218:22-28.
14. Lamb NE, Freeman SB, Savage-Austin A, Pettay D, Taft L, Hershey J, Gu YC, Shen J, Saker D, May KM, Avramopoulos D, Petersen MB, Hallberg A, Mikkelsen M, Hassold TJ, Sherman SL. Susceptible chiasmate configurations of chromosome 21 predispose to non-disjunction in both maternal meiosis I and meiosis II. Nat Genet 1996;14:400-405.
15. Angell RR, Xian J, Keith J, Ledger W, Baird DT. First meiotic division abnormalities in human oocytes: Mechanism of trisomy formation. Cytogenet Cell Genet 1994;65:194-202.
16. Angell RR. First-meiotic division nondisjunction in human oocytes. Am J Hum Genet 1997;61:23-32.
17. Steuerwald N, Cohen J, Herrera RJ, Sandalinas M, Brenner CA. Association between spindle assembly checkpoint expression and maternal age in human oocytes. Mol Hum Reprod 2001;7:49-55.
18. Steuerwald N, Steuerwald MD, Mailhes JB. Postovulatory aging of mouse oocytes leads to decreased MAD2 transcripts and increased frequencies of premature centromere separation and anaphase. Mol Hum Reprod 2005;11:623-630.
19. Homer HA, Mcdougall A, Levasseur M, Yallop K, Murdoch AP, Herbert M. Mad2 prevents aneuploidy and premature proteolysis of cyclin B and securin during meiosis I in mouse oocytes. Genes Dev 2005;19:202-207.
20. Angell RR. Predivision in human oocytes at meiosis I: A mechanism for trisomy formation in man. Hum Genet 1991;86:383-387.
21. Wolstenholme J, Angell RR. Maternal age and trisomy-a unifying mechanism of formation. Chromosoma 2000;109:435-438.
22. Sun FY, Schmid TE, Schmid E, Baumgartner A, Adler I-D. Trichlorfon induces spindle disturbances in V79 cells and aneuploidy in male mouse germ cells. Mutagenesis 2000;15:17-24.
23. Eichenlaub-Ritter U. Aneuploidy in aging oocytes and after toxic insult. In: Trounson A, Gosden RG, Eds. Biology and Pathology of the Oocyte; Its Role in Fertility and Reproductive Medicine. Cambridge, UK: Cambridge University Press, 2003:220-257.
24. Dekel N. Regulation of oocyte maturation: The role of cAMP. Ann NY Acad Sci 1988;541:211-216.
25. Schultz RM, Montgomery RR, Belanoff JR. Regulation of mouse oocyte maturation: Implication of a decrease in oocyte cAMP and protein dephosphorylation in commitment to resume meiosis. Dev Biol 1983;797:264-273.
26. Schultz RM. Regulatory functions of protein phosphorylation in meiotic maturation of mouse oocytes in vitro. In: Haseltine FP, First NL, Eds. Meiotic Inhibition: Molecular Control of Meiosis. New York: Alan R. Liss, 1988:137-151.
27. Racowsky C. Somatic control of meiotic status in mammalian oocytes. In: Haseltine FP, Heyner S. Eds. Meiosis II, Contemporary Approaches to the Study of Meiosis. Washington, DC: American Association for the Advancement of Science Press, 1993:107-116.
28. Yamasita M, Mita K, Yoshida N, Kondo T. Molecular mechanisms of the initiation of oocyte maturation: General and species-specifi c aspects. Prog Cell Cycle Res 2000;4:115-129.
29. Boernslaeger EA, Mattei P, Schultz RM. Involvement of cAMPdependent protein kinase and protein phosphorylation in regulation of mouse oocyte maturation. Dev Biol 1986;114:453-462.
30. Downs SM, Daniel SAJ, Bornslaeger EA, Hoppe PC, Eppig JJ. Maintenance of meiotic arrest in mouse oocytes by purines: Modulation of cAMP levels and cAMP phosphodiesterase activity. Gamete Res 1989;23:323-334.
31. Dunphy WG, Kumagai A. The cdc25 protein contains an intrinsic phosphatase activity. Cell 1991;67:189-196.
32. Gautier J, Solomon MJ, Booher RN, Bazan JF, Kirschner ME. cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 1991;67:197-211.
33. Strausfeld U, Labbe JC, Fesquet D, Cavadore JC, Picard A, Sadhu K, Russell P, Doree M. Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature 1991;351:242-245.
34. Arion D, Meifer L, Brizuela L, Beach D. cdc2 is a component of the M phase-specific histone H1 kinase: Evidence for identity with MPF. Cell 1988;55:371-378.
35. Draetta G, Beach D. Activation of cdc2 protein kinase during mitosis in human cells: Cell cycle dependent phosphorylation and subunit rearrangement. Cell 1988;54:17-26.
36. Choi T, Aoki F, Mori M, Yamashita M, Nagahama Y, Kohmoto K. Activation of p34cdc2 protein kinase activity in meiotic and mitotic cell cycles in mouse oocytes and embryos. Development 1991; 113:789-795.
37. Fulka J Jr, Jung T, Moor RM. The fall of biological maturation promoting factor (MPF) and histone H1 kinase activity during anaphase and telophase in mouse oocytes. Mol Reprod Dev 1992;32:378-382.
38. Collas P, Sullivan EJ, Barnes FL. Histone H1 kinase activity in bovine oocytes following calcium stimulation. Mol Reprod Dev 1993;34:224-231.
39. Kikuchi K, Izaike Y, Noguchi J, Furukawa T, Daen FP, Naito K, Toyoda Y. Decrease of histone H1 kinase activity in relation to parthenogenetic activation of pig follicular oocytes matured and aged in vitro. J Reprod Fertil 1995;105:325-330.
40. Murray AW. MAP kinases in meiosis. Cell 1998;92:157-159.
41. Takenaka K, Moriguchi T, Nishida E. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 1998;280:599-602.
42. Sobajima T, Aoki F, Kohomoto K. Activation of mitogen-activated protein kinase during meiotic maturation in mouse oocytes. J Reprod Fertil 1993;97:389-394.
43. Verlhac MH, Kubiak JZ, Clarke HJ, Maro BH. Microtubule and chromatin behavior follow MAP kinase activity but not MPF activity during meiosis in mouse oocytes. Development 1994;120: 1017-1025.
44. Paules RS, Buccione R, Moschel RC, Vande Woude GF, Eppig JJ. Mouse mos protooncogene product is present and functions during oogenesis. Proc Natl Acad Sci USA 1989;86:5395-5399.
45. Sagata N. What does Mos do in oocytes and somatic cells? BioEssays 1997;19:13-21.
46. Singh B, Arlinghaus RB. Mos and the cell cycle. Prog Cell Cycle Res 1997;3:251-259.
47. Dekel N. Protein phosphorylation-dephosphorylation in the meiotic cell cycle of mammalian oocytes. Rev Reprod 1996;1:82-88.
48. Sagata N. Meiotic metaphase arrest in animal oocytes: Its mechanisms and biological signifi cance. Trends Cell Biol 1996;6: 22-28.
49. Hashimoto N. Role of c-mos proto-oncogene product in the regulation of mouse oocyte maturation. Horm Res 1996;46:11-14.
50. Colledge WH, Carlton MBL, Udy GB, Evans MJ. Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs. Nature 1994;370:65-68.
51. Hashimoto N, Watanabe N, Furuta Y, Tamemoto H, Sagata N, Yokoyama M, Okazaki K, Nagayoshi M, Takeda N, Ikawa Y, et al. Parthenogenetic activation of oocytes in c-mos deficient mice. Nature 1994;370:68-71.
52. Hyman AA, Mitchison TJ. Two different microtubule-based motor activities with opposite polarities in kinetochores. Nature 1991;351: 206-211.
53. Karsenti E. Mitotic spindle morphogenesis in animal cells. Semin Cell Biol 1991;4:251-260.
54. Dorée M, Le Peuch C, Morin N. Onset of chromosome segregation at the metaphase to anaphase transition of the cell cycle. Prog Cell Cycle Res 1995;1:309-318.
55. Santella L. The role of calcium in the cell cycle: Facts and hypotheses. Biochem Biophys Res Commun 1998;244:317-324.
56. Jesus C, Rime H, Haccard O, Van Lint J, Goris J, Merlevede W, Ozon R. Tyrosine phosphorylation of p34cdc2 and p42 during meiotic maturation of Xenopus oocyte: Antagonistic action of okadaic acid and 6-DMAP. Development 1991;111:813-820.
57. Cohen P, Holmes CF, Tsukitani Y. Okadaic acid: A new probe for the study of cellular regulation. Trends Biochem Sci 1990;15: 98-102.
58. Schönthal S. Okadaic acid-a valuable new tool for the study of signal transduction and cell cycle regulation? New Biol 1992;4:16-21.
59. Schwartz DA, Schultz RM. Stimulatory effect of okadaic acid, an inhibitor of protein phosphorylation in mouse oocytes and one-cell zygotes. Dev Biol 1991;145:119-127.
60. Vandre DD, Willis VL. Inhibition of mitosis by okadaic acid: Possible involvement of a protein phosphatase 2A in the transition from metaphase to anaphase. J Cell Sci 1992;101:79-91.
61. Zernicka-Goetz M, Kubiak JZ, Antony C, Maro B. Cytoskeletal organization of rat oocytes during metaphase II arrest and following abortive activation: A study by confocal laser scanning microscopy. Mol Reprod Dev 1993;35:165-175.
62. De Pennart H, Helene-Verlhac M, Cibert C, Santa Maria A, Maro B. Okadaic acid induces spindle lengthening and disrupts the interaction of microtubules with the kinetochores in metaphase IIarrested mouse oocytes. Dev Biol 1993;157:170-181.
63. Mailhes JB, Hilliard C, Fuseler JW, London SN. Okadaic acid, an inhibitor of phosphatase 1 and 2A, induces premature separation of sister chromatids during meiosis I and aneuploidy in mouse oocytes in vitro. Chromosome Res 2003;11:619-631.
64. Rime H, Neant I, Guerrier P, Ozon R. 6-Dimethylaminopurine (6-DMAP), a reversible inhibitor of the transition to metaphase during the first meiotic cell division of the mouse oocyte. Dev Biol 1989;133:169-179.
65. Szollosi MS, Kubiak JZ, Debey P, de Pennart H, Szollosi D, Maro B. Inhibition of protein kinases by 6-dimethylaminopurine accelerates the transition to interphase in activated mouse oocytes. J Cell Sci 1993;104:861-872.
66. Spielmann H, Krüger C, Stauber M, Vogel R. Abnormal chromosome behavior in human oocytes which remained unfertilized during human in vitro fertilization. J In Vitro Fertil Embryo Transf 1985;2:138-142.
67. Saito H, Koike K, Saito T, Nohara M, Kawagoe S, Hiroi M. Aging changes in the alignment of chromosomes after human chorionic gonadotropin stimulation may be a possible cause of decreased fertility in mice. Horm Res 1993;39:28-31.
68. Sakurada K, Ishikawa H, Endo A. Cytogenetic effects of advanced maternal age and delayed fertilization on first-cleavage mouse embryos. Cytogenet Cell Genet 1996;72:46-49.
69. Dailey T, Dale B, Cohen J, Nunné S. Association between nondisjunction and maternal age in meiosis II oocytes. Am J Hum Genet 1996;59:176-184.
70. Mailhes JB, Young D, London SN. 1,2-Propanediol-induced premature centromere separation in mouse oocytes and aneuploidy in one-cell zygotes. Biol Reprod 1997;57:92-98.
71. Mailhes JB, Young D, London SN. Postovulatory ageing of mouse oocytes in vivo and premature centromere separation and aneuploidy. Biol Reprod 1998;58:1206-1210.
72. Orth JM, Qiu JP, Jester WF, Pilder S. Expression of the c-kit gene is critical for migration of neonatal rat gonocytes in vitro. Biol Reprod 1997;57:676-683.
73. Handel MA, Cobb J, Eaker S. What are the spermatocyte's requirements for successful meiotic division? J Exp Zool 1999;285: 243-250.
74. Inselman A, Eaker S, Handel MA. Temporal expression of cell cycle-related proteins during spermatogenesis: Establishing a timeline for the onset of the meiotic divisions. Cytogenet Genome Res 2003;103:277-284.
75. Wiltshire T, Park C, Caldwell KA, Handel MA. Induced premature G2/M-phase transition in pachytene spermatocytes includes events unique to meiosis. Dev Biol 1995;169:557-567.
76. Kimura Y, Tateno H, Handel MA, Yanagimachi R. Factors affecting meiotic and developmental competence of primary spermatocyte nuclei injected into mouse oocytes. Biol Reprod 1998;59: 871-877.
77. Allen JW, Liang JC, Carrano AV, Preston RJ. Review of literature on chemical-induced aneuploidy in mammalian male germ cells. Mutat Res 1986;167:123-137.
78. Mailhes JB, Preston RJ, Lavappa KS. Mammalian in vivo assays for aneuploidy in female germ cells. Mutat Res 1986;167: 139-148.
79. Mailhes JB, Marchetti F. Chemically-induced aneuploidy in mammalian oocytes. Mutat Res 1994;320:87-111.
80. Mailhes JB, Preston RJ, Yuan ZP, Payne HS. Analysis of mouse metaphase II oocytes as an assay for chemically induced aneuploidy. Mutat Res 1988;198:145-152.
81. Mailhes JB, Yuan ZP, Aardema MJ. Cytogenetic analysis of mouse oocytes and one-cell zygotes as a potential assay for heritable germ cell aneuploidy. Mutat Res 1990;242:89-100.
82. Adler I-D, Schmid TE, Baumgartner A. Induction of aneuploidy in male mouse germ cells detected by the sperm-FISH assay: A review of the present data base. Mutat Res 2002;504:173-182.
83. Akeson EC, Lambert JP, Narayanswami S, Gardiner K, Bechtel LJ, Davisson MT. Ts65Dn-localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome. Cytogenet Cell Genet 2001;93:270-276.
84. Davisson MT. Mouse models of Down syndrome. Drug Discov Today: Dis Models 2005;2:103-109.
85. Davisson MT, Costa ACS. Mouse models of Down syndrome. In: Popko B, Ed. Mouse Models in the Study of Genetic Neurological Disorders. Advances in Neurochemistry, Vol. 9. New York: Kluwer Academic/Plenum, 1999.
86. Sago H, Carlson EJ, Smith DJ, Kilbridge J, Rubin EM, Mobley WC, Epstein CJ, Huang TT. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci USA 1998;95:6256-6261.
87. O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Sesay A, Modino S, Vanes L, Hernandez D, Linehan JM, Sharpe PT, Brandner S, Bliss TV, Henderson DJ, Nizetic D, et al. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 2005;309(5743):2033-2037.
88. Villar AJ, Belichenko PV, Gillespie AM, Kozy HM, Mobley WC, Epstein CJ. Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12. Mamm Genome 2005;16:79-90.
89. Reeves RH, Irving NG, Moran T, Wohn A, Sisodia SS, Schmidt C, Davisson MT. A mouse model for Down syndrome exhibits learning and behavior defi cits. Nat Genet 1995;11:177-183.
90. Hunt PA, Worthman C, Levinson H, Stallings J, LeMaire R, Mroz K, Park C, Handel MA. Germ cell loss in the XXY male mouse: Altered X chromosome dosage affects prenatal development. Mol Reprod Dev 1998;49:101-111.
91. Mroz K, Hassold TJ, Hunt PA. Meiotic aneuploidy in the XXY mouse: Evidence that a compromised testicular environment increases the incidence of meiotic errors. Hum Reprod 1999;14: 1151-1156.
92. Burgoyne PS, Ojarikre OA, Tuner JMA. Evidence that postnatal growth retardation in XO mice is due to haploinsufficiency for a non-PAR X gene. Cytogenet Genome Res 2002;99:252-256.
93. Hodges CA, LeMaire-Adkins R, Hunt PA. Coordinating the segregation of sister chromatids during the first meiotic division: Evidence for sexual dimorphism. J Cell Sci 2001;114:2417-2426.
94. Dobson MJ, Pearlman RE, Karaiskakis A, Spyropoulos B, Moens PB. Synaptonemal complex proteins: Occurrence, epitope mapping and chromosome disjunction. J Cell Sci 1994;107:2749-2760.
95. Parra MT, Viera A, Gomez R, Page J, Benavente R, Santos JL, Rufas JS, Suja JA. Involvement of the cohesion Rad21 and Scp3 in monopolar attachment of sister kinetochores during mouse meiosis I. J Cell Sci 2004;117:1221-1234.
96. Yuan L, Liu JG, Zhao J, Brundell E, Daneholt B, Hoog C. The murine SCP3 gene is required for synaptonemal complex assembly, chromosome synapsis, and male fertility. Mol Cell 2000;5:73-83.
97. Yuan L, Liu JG, Hoja MR, Wilbertz J, Nordqvist K, Hoog C. Female germ cell aneuploidy and embryo death in mice lacking the meiosis-specifi c protein SCP3. Science 2002;296:1115-1118.
98. Wang H, Hoog C. Structural damage to meiotic chromosomes impairs DNA recombination and checkpoint control in mammalian oocytes. J Cell Biol 2006;173:485-495.
99. Revenkova E, Eijpe M, Heyting C, Gross B, Jessberger R. Novel meiosis-specifi c isoform of mammalian SMC1. Mol Cell Biol 2001;21:6984-6998.
100. Revenkova E, Eifpe M, Heyting C, Hodges CA, Hunt PA, Liebe B, Scherthan H, Jessberger R. Cohesin SMC1beta is required for meiotic chromosome dynamics, sister chromatid cohesion and DNA recombination. Nat Cell Biol 2004;6:555-562.
101. Hodges CA, Revenkova E, Jessberger R, Hassold T, Hunt PA. SMC1beta-defi cient female mice provide evidence that cohesions are a missing link in age-related nondisjunction. Nat Genet 2005;37:1351-1355.
102. Hunter N, Borts RH. Mlh1 is unique among mismatch repair proteins in its ability to promote crossing-over during meiosis. Genes Dev 1997;11:1573-1582.
103. Baker S, Plug A, Prolla T, Bronner C, Harris A, Yao X, Christie DM, Monell C, Arnheim N, Bradley A, et al. Involvement of mouse MLH1 in DNA mismatch repair and meiotic crossing over. Nat Genet 1996;13:336-342.
104. Edelmann W, Cohen PE, Kane M, Lau K, Morrow B, Bennett S, Umar A, Kunkel T, Cattoretti G, Chaganti R, et al. Meiotic pachytene arrest in MLH1-deficient mice. Cell 1996;85:1125-1134.
105. Eaker S, Cobb J, Pyle A, Handel MA. Meiotic prophase abnormalities and metaphase cell death in MLH1-deficient mouse spermatocytes: Insights into regulation of spermatogenic progress. Dev Biol 2002;249:85-95.
106. Woods LM, Hodges CA, Baart E, Baker SM, Liskay M, Hunt PA. Chromosomal influence on meiotic spindle assembly: Abnormal meiosis I in female MLh1 mutant mice. J Cell Biol 1999;145:1395-1406.
107. Anderson LK, Reeves A, Webb LM, Ashley T. Distribution of crossing over on mouse synaptonemal complexes using immunofl uorescent localization of MLH1 protein. Genetics 1999;151:1569-1579.
108. Lipkin SM, Moens PB, Wang V, Lenzi M, Shanmugarajah D, Gilgeous A, Thomas J, Cheng J, Touchman JW, Green ED, Schwartzberg P, Collins FS, Cohen PE. Meiotic arrest and aneuploidy in MLH3-deficient mice. Nat Genet 2002;31:385-390.
109. De La Fuente R, Viveiros MM, Wigglesworth K, Eppig JJ. ATRX, a member of the SNF2 family of helicase/ATPases, is required for chromosome alignment and meiotic spindle organization in metaphase II stage mouse oocytes. Dev Biol 2004;272:1-14.
110. Champoux JJ. DNA topoisomerases: Structure, function, and mechanism. Annu Rev Biochem 2001;70:369-413.
111. Kwan KY, Moens PB, Wang JC. Infertility and aneuploidy in mice lacking a type IA DNA topoisomerase IIIbeta. Proc Natl Acad Sci USA 2003;100:2526-2531.
112. Cobb J, Reddy RK, Park C, Handel MA. Analysis of expression and function of topoisomerase I and II during meiosis in male mice. Mol Reprod Dev 1997;46:489-498.
113. Nasmyth K. How do so few control so many? Cell 2005;120: 739-746.
114. Baker DJ, Jeganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A, Kumar R, Jenkins RB, de Groen PC, Roche P, van Deursen JM. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 2004; 36:744-749.
115. Dobles M, Liberal V, Scott ML, Benerza R, Sorger PK. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 2000;101:635-645.
116. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Lorger PK, Murty VVVS, Benerza R. MAD2 haplo-insuffi ciency causes premature anaphase and chromosome instability in mammalian cells. Nature 2001;409:355-359.
117. Libby BJ, DeLaFuente R, O'Brien MJ, Wigglesworth K, Cobb J, Inselman A, Eaker S, Handel MA, Eppig JJ, Schimenti JC. The mouse meiotic mutation mei1 disrupts chromosome synapsis with sexually dimorphic consequences for meiotic progression. Dev Biol 2002;242:174-187.
118. Bannister LA, Reinholdt LG, Munroe RJ, Schimenti JC. Positional cloning and characterization of mouse mei8, a disrupted allele of the meiotic cohesin Rec8. Genesis 2004;40:184-194.
119. Pyle A, Handel MA. Meiosis in male PL/J mice: A genetic model for gametic aneuploidy. Mol Reprod Dev 2003;64:471-481.
120. Liu L, Keefe DL. Aging-associated aberration in meiosis of oocytes from senescence-accelerated mice. Hum Reprod 2002;17:2678-2685.
121. Pacchierotti F. Chemically induced aneuploidy in germ cells of mouse. In: Vig BK, Sandberg AA, Eds. Aneuploidy, Part B: Induction and Test Systems, Progress and Topics in Cytogenetics, Vol. 7b. New York: Alan R. Liss, 1988:123-139.
122. Mailhes JB, Marchetti F. Mechanisms and chemical induction of aneuploidy in rodent germ cells. Cytogenet Genome Res 2005;111: 384-391.
123. Mailhes JB, Mastromatteo C, Fuseler JW. Transient exposure to the EG5 kinesin inhibitor monastrol leads to syntelic orientation of chromosomes and aneuploidy in mouse oocytes. Mutat Res 2004;559:153-167.
124. Hunt PA, Koehler KE, Susiarjo M, Hodges CA, Ilagan A, Voight RC, Thomas S, Thomas BF, Hassold TJ. Bisphenol a exposure causes meiotic aneuploidy in the female mouse. Curr Biol 2003;13: 546-553.
125. Bean CJ, Hassold TJ, Judis L, Hunt PA. Fertilization in vitro increases non-disjunction during early cleavage divisions in a mouse model system. Hum Reprod 2002;17:2362-2367.
126. Tepperberg JH, Moses MJ, Nath J. Colchicine effects on meiosis in the male mouse .1. Meiotic prophase: Synaptic arrest, univalents, loss of damaged spermatocytes and a possible checkpoint at pachytene. Chromosoma 1997;106:183-192.
127. Tepperberg JH, Moses MJ, Nath J. Colchicine effects on meiosis in the male mouse-II. Inhibition of synapsis and induction of nondisjunction. Mutat Res 1999;429:93-105.
128. Allen JW, Gibson JB, Poorman PA, Backer LC, Moses MJ. Synaptonemal complex damage induced by clastogenic and anti-mitotic chemicals: Implications for non-disjunction and aneuploidy. Mutat Res 1988;201:313-324.
129. Backer LC, Gibson JB, Moses MJ, Allen JW. Synaptonemal complex damage in relation to meiotic chromosome aberrations after exposure of male mice to cyclophosphamide. Mutat Res 1988;203:317-330.
130. Russell LB, Hunsicker PR, Johnson DK, Shelby MD. Unlike other chemicals, etoposide (a topoisomerase-II inhibitor) produces peak mutagenicity in primary spermatocytes of the mouse. Mutat Res 1998;400:279-286.
131. Russell LB, Hunsicker PR, Hack AM, Ashley T. Effect of the topoisomerase-II inhibitor etoposide on meiotic recombination in male mice. Mutat Res 2000;464:201-212.
132. Marchetti F, Bishop JB, Lowe X, Generoso WM, Hozier J, Wyrobek AJ. Etoposide induces heritable chromosomal aberrations and aneuploidy during male meiosis in the mouse. Proc Natl Acad Sci USA 2001;98:3952-3957.
133. Russell LB, Hunsicker PR, Kerley M, Pyle A, Saxton AM. Etoposide exposure during male mouse pachytene has complex effects on crossing-over and causes nondisjunction. Mutat Res 2004;565: 61-77.
134. Russell LB. Effects of male germ-cell stage on the frequency, nature and spectrum of induced specific-locus mutations in the mouse. Genetica 2004;122:25-36.
135. Davisson MT, Handel MA. Cytogenetics. In: Smith AG, Ed. The Mouse in Biomedical Research. Amsterdam, The Netherlands: Elsevier, 2006:146-164.
136. Attia SM, Schmid TE, Badary OA, Hamada FM, Adler ID. Molecular cytogenetic analysis in mouse sperm of chemically induced aneuploidy: Studies with topoisomerase II inhibitors. Mutat Res 2002;520:1-13.
137. Marchetti F, Pearson FS, Bishop JB, Wyrobek AJ. Etoposide induces chromosomal abnormalities in mouse spermatocytes and stem cell spermatogonia. Hum Reprod 2006;21:888-895.
138. De Mas P, Daudin M, Vincent MC, et al. Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin. HumReprod 2001;16:1204-1208.
139. Baumgartner A, Schmid TE, Schuetz CG, Adler ID. Detection of aneuploidy in rodent and human sperm by multicolor FISH after chronic exposure to diazepam. Mutat Res 2001;490:11-19.
140. Marchetti F, Lowe X, Moore DI, Bishop J, Wyrobek AJ. Paternally inherited chromosomal structural aberrations detected in mouse fi rst-cleavage zygote metaphases by multicolor fluorescence in situ hybridization painting. Chromosome Res 1996;4:604-613.
141. Marchetti F, Bishop JB, Cosentino L, Moore D, 2nd, Wyrobek AJ. Paternally transmitted chromosomal aberrations in mouse zygotes determine their embryonic fate. Biol Reprod 2004;70: 616-624.
142. Hafez ESE. Reproduction in Farm Animals, 6th ed. Philadelphia, PA: Lea & Febiger, 1993:144-164.
143. Juberg RC. Origin of chromosomal abnormalities: Evidence for delayed fertilization in meiotic nondisjunction. Hum Genet 1983;64:122-127.
144. Blazak WF. Incidence of aneuploidy in farm animals. In: Vig BK, Sandberg AA, Eds. Aneuploidy, Part A: Incidence and Etiology. New York: Alan R. Liss, 1987:103-116.
145. Mailhes JB. Incidence of aneuploidy in rodents. In: Vig BK, Sandberg AA, Eds. Aneuploidy, Part A: Incidence and Etiology. New York: Alan R. Liss,1987:67-101.
146. Pellestor F. Frequency and distribution of aneuploidy in human female gametes. Hum Genet 1991;86:283-288.
147. Zenzes MT, Casper RF. Cytogenetics of human oocytes, zygotes, and embryos after in vitro fertilization. Hum Genet 1992;88: 367-375.
148. Wilcox AJ, Weinberg CR, Baird DD. Post-ovulatory ageing of the human oocyte and embryo failure. Hum Reprod 1998;13:394-397.
149. Lewis WH, Wright ES. On the early development of the mouse egg. Carnegie Inst Contrib Embryol 1935;25:113-143.
150. Edwards RG, Gates AH. Timing of the stages of the maturation divisions, ovulation, fertilization and the first cleavage of eggs of adult mice treated with gonadotrophins. J Endocrinol 1959;18:292-304.
151. Marston JH, Chang MC. The fertilizable life of ova and their morphology following delayed insemination in mature and immature mice. J Exp Zool 1964;155:237-252.
152. Exley GE, Tang C, McElhinny AS, Warner CM. Expression of caspase and BCL-2 apoptotic family members in mouse preimplantation embryos. Biol Reprod 1999;61:231-239.
153. Morita Y, Tilly JL. Oocyte apoptosis: Like sand through an hourglass. Dev Biol 1999;213:1-17.
154. Perez GI, Tao XJ, Tilly JL. Fragmentation and death (a.k.a. apoptosis) of ovulated oocytes. Mol Human Reprod 1999;5:414-420.
155. Gordo AC, Rodrigues P, Kurokawa M, Jellerette T, Exley GE, Warner C, Fissore R. Intracellular calcium oscillations signal apoptosis rather than activation in in vitro aged mouse eggs. Biol Reprod 2002;66:1828-1837.
156. Warburton D. Biological aging and the etiology of aneuploidy. Cytogenet Genome Res 2005;111:266-272.
157. Hodges CA, Ilagan A, Jennings D, Keri R, Nilson J, Hunt PA. Experimental evidence that changes in oocyte growth influence meiotic chromosome segregation. Hum Reprod 2002;17:1171-1180.
158. Yanagida M. Basic mechanisms of eukaryotic chromosome segregation. Phil Trans R Soc B 2005;360:609-621.
159. Schlecht U, Primig M. Mining meiosis and gametogenesis with DNA microarrays. Reproduction 2003;125:447-456.
160. Stein P, Svoboda P, Schultz RM. Transgenic RNAi in mouse oocytes: A simple and fast approach to study gene function. Dev Biol 2003;256:187-193.
161. Bettencourt-Dias M, Giet R, Sinka R, Mazumdar A, Lock WG, Balloux PJ, Safiropoulos PJ, Yamaguchi S, Winter S, Carthew RW, Cooper M, Jones D, Frenz L, Glover DM. Genome-wide survey of protein kinases required for cell cycle progression. Nature 2004;432:980-987.
162. Prawitt D, Brixel L, Spangenberg C. Eshkind L, Heck R, Oesch F, Zabel B, Bockamp E. RNAi knock-down mice: An emerging technology for post-genomic functional genetics. Cytogenet Genome Res 2004;105:412-421.
163. Gregan J, Rabitsch PK, Sakem B, Csutak O, Latypov V, Lehmann E, Kohli J, Nasmygh K. Novel genes required for meiotic chromosome segregation are identified by a high-throughput knockout screen in fission yeast. Curr Biol 2005;15:1663-1669.
164. Marston AL, Tham WH, Shah H, Amon A. A genome-wide screen identifi es genes required for centromeric cohesion. Science 2004;303:1367-1370.
165. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. Large-scale metaanalysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004;101:9309-9314.
166. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004; 432:338-341.
167. Mailhes JB, Hilliard C, Lowery M, London SN. MG-132, an inhibitor of proteasomes and calpains, induced inhibition of oocyte maturation and aneuploidy in mouse oocytes. Cell Chromosome 2002;1:2.
168. Mailhes JB, Hilliard C, Fuseler JW, London SN. Vanadate, an inhibitor of tyrosine phosphatases, induced premature anaphase in oocytes and aneuploidy and polyploidy in mouse bone marrow cells. Mutat Res 2003;538:101-107.